Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies

Journal of the American College of Surgeons

Volumn 191, Issue 5, 2000, Pages 519-530

  Libutti, Steven K ^a   Bartlett, David L ^a   Fraker, Douglas L ^b   Alexander, H Richard ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELPHALAN; TUMOR NECROSIS FACTOR;

ARTICLE; BLEEDING; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; HYPERTHERMIA; INOPERABLE CANCER; LAPAROTOMY; LIVER BLOOD FLOW; LIVER CANCER; LIVER PERFUSION; MORBIDITY; MORTALITY; OPERATION DURATION; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; SHUNTING; TECHNIQUE; TRANSFUSION; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; LIVER NEOPLASMS; MALE; MELPHALAN; MIDDLE AGED; SERUM ALBUMIN, RADIO-IODINATED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033735111     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(00)00733-X     Document Type: Article

References (30)

1. Metastatic cancer to the liver
2. Hemotagenous metastatic patterns in colonic carcinoma: An analysis of 1541 necropsies
3. Prognostic indicators following enucleation for posterior uveal melanoma
4. Transcatheter treatment of hepatic metastases
5. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update
6. Development of a technic for isolated perfusion of the liver
7. Die isolierte leberperfusion mit 5-fluorouracil (5-FU) beim menschen
8. First experimental and dinical results of isolated liver perfusion with cytotoxics in metastases from colorectal primary
9. Rationale and indications for perfusion in liver tumors: Current data
10. Isolated liver perfusion with mitomycin C in the treatment of colorectal cancer metastases confined to the liver
11. Isolated hyperthermic liver perfusion with chemotherapy for liver malignancy
12. Isolated limb perfusion for malignant melanoma
13. The use of TNF in isolated limb perfusion: Results and side effects. The NCI results
14. Isolation limb perfusion with tumor necrosis factor alpha and chemotherapy for advanced extremity soft tissue sarcomas
15. Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver
16. Isolated hepatic perfusion with tumor necrosis factor alpha and melphalan: Experimental studies in pigs and phase I data from humans
17. Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia TNF alpha and melphalan: Swedish experience
18. Delivery of anticancer drugs via isolated hepatic perfusion: A promising strategy in the treatment of irresectable liver metastases?
19. Cytokine levels and systemic toxicity in patients undergoing isolated limb perfusion (ILP) with high-dose TNF, interferon-gamma and melphalan
20. First experience and technical aspects of isolated liver perfusion for extensive liver metastasis
21. Isolated hepatic infusion perfusion (IHP) with TNF
22. Continuous intraoperative external monitoring of perfusate leak using I-131 human serum albumin during isolated perfusion of the liver and limbs
23. Limb perfusion with TNF: Current status of United States trials
24. An evaluation of 51 patients with hepatic artery infusion
25. Cryosurgery of liver cancer
26. The use of TNF in isolated limb perfusion for treatment of locally advanced melanoma: An update
27. Die isolierte leberperfusion bei fortgeschrittenen metastasen kolorektaler karzinome
28. Isolated liver perfusion with mitomycin-C or melphalan in patients with hepatic metastases
29. Continuous leaking monitoring during hyperthermic isolated regional perfusion of the lower limb: Techniques and results
30. Systemic leakage during isolated limb perfusion for melanoma